Showing results (261-270 of 2,755) with videos related to

Sort By:
Pageof 276
Pharmacogenomics|February 28, 2019
Differential long noncoding RNAs expression in cancer-associated fibroblasts of non-small-cell lung cancerCuifang Teng, Guolin Huang, Yanmei Luo, et al.
Pharmacogenomics|September 6, 2019
Lethal toxicities after capecitabine intake in a previously 5-FU-treated patient: why dose matters with dihydropryimidine dehydrogenase deficiencyCrescent C Gbeto, Sylvie Quaranta, Roxane Mari, et al.
Pharmacogenomics|February 4, 2021
Pharmacogenomics education and perceptions: is there a gap between internal medicine resident and attending physicians?Carolyn R Rohrer Vitek, Jyothsna Giri, Pedro J Caraballo, et al.
Pharmacogenomics|April 1, 2011
Systems pharmacology assessment of the 5-fluorouracil pathwayFilipe A Muhale, Barbara A Wetmore, Russell S Thomas, et al.
Pharmacogenomics|April 1, 2011
Use of a comprehensive panel of biomarkers to predict response to a fluorouracil-oxaliplatin regimen in patients with metastatic colorectal cancerMaria J Lamas, Goretti Duran, Emilia Balboa, et al.
Pharmacogenomics|June 4, 2011
Impact of the CYP3A4*1G polymorphism and its combination with CYP3A5 genotypes on tacrolimus pharmacokinetics in renal transplant patientsMasatomo Miura, Shigeru Satoh, Hideaki Kagaya, et al.
Pharmacogenomics|April 28, 2011
Diagnostics and personalized medicine: observations from the World Companion Diagnostics SummitMark E Curran, Suso Platero
Pharmacogenomics|April 28, 2011
Variability in transport and biotransformation of cytarabine is associated with its toxicity in peripheral blood mononuclear cellsSumit Parmar, Angela Seeringer, Dina Denich, et al.
Pharmacogenomics|April 28, 2011
Role of the XRCC5/XRCC6 dimer in carcinogenesis and pharmacogenomicsDa-Tian Bau, Chia-Wen Tsai, Cheng-Nan Wu
Pharmacogenomics|April 28, 2011
Pharmacogenetics of drug-induced birth defects: what is known so far?Bob Wilffert, Judith Altena, Laurien Tijink, et al.
Pageof 276